Prognostic Role of Survivin in Bladder Cancer: A Systematic Review and Meta-Analysis

Correlation of tumor relapse and elevated expression of survivin and vascular endothelial growth factor in superficial bladder transitional cell carcinoma

(2013) Y.W. Sun et al.   GENETICS AND MOLECULAR RESEARCH

Cyclooxygenase-2 and Survivin in Superficial Urothelial Carcinoma of the Bladder and Correlation with Intratumoural Microvessel Density

(2013) U Yildirim et al.   JOURNAL OF INTERNATIONAL MEDICAL RESEARCH

Cathepsin E, Maspin, Plk1, and Survivin Are Promising Prognostic Protein Markers for Progression in Non-Muscle Invasive Bladder Cancer

(2012) Niels Fristrup et al.   AMERICAN JOURNAL OF PATHOLOGY

Expression of survivin and livin predicts early recurrence in non-muscle invasive bladder cancer

(2012) Ren Chong Xi et al.   JOURNAL OF SURGICAL ONCOLOGY

Functional polymorphisms in promoter survivin gene and its association with susceptibility to bladder cancer in North Indian cohort

(2011) Praveen Kumar Jaiswal et al.   MOLECULAR BIOLOGY REPORTS

ErbB2 and NFκB Overexpression as Predictors of Chemoradiation Resistance and Putative Targets to Overcome Resistance in Muscle-Invasive Bladder Cancer

(2011) Fumitaka Koga et al.   PLoS One

Detection of Nuclear Matrix Protein 22 and Survivin Baseline Level in Patients after Radical Cystectomy

(2011) Zhi-Long Dong et al.   UROLOGIA INTERNATIONALIS

Association of tumor-associated trypsin inhibitor (TATI) expression with molecular markers, pathologic features and clinical outcomes of urothelial carcinoma of the urinary bladder

(2011) Oliver Patschan et al.   WORLD JOURNAL OF UROLOGY

Prognostic significance of survivin-expressing circulating tumour cells in T1G3 bladder cancer

(2010) Angela Gradilone et al.   BJU INTERNATIONAL

Cancer Statistics, 2010

(2010) A. Jemal et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Association of Angiogenesis Related Markers With Bladder Cancer Outcomes and Other Molecular Markers

(2010) Shahrokh F. Shariat et al.   JOURNAL OF UROLOGY

Genoproteomic Mining of Urothelial Cancer Suggests γ-Glutamyl Hydrolase and Diazepam-Binding Inhibitor as Putative Urinary Markers of Outcome after Chemotherapy

(2009) Courtney Pollard et al.   AMERICAN JOURNAL OF PATHOLOGY

Modest effect of p53, EGFR and HER-2/neu on prognosis in epithelial ovarian cancer: a meta-analysis

(2009) P de Graeff et al.   BRITISH JOURNAL OF CANCER

Survivin as a Prognostic Marker for Urothelial Carcinoma of the Bladder: A Multicenter External Validation Study

(2009) S. F. Shariat et al.   CLINICAL CANCER RESEARCH

Predicting Recurrence and Progression of Noninvasive Papillary Bladder Cancer at Initial Presentation Based on Quantitative Gene Expression Profiles

(2009) Marc Birkhahn et al.   EUROPEAN UROLOGY

Survivin Expression as a Predictive Marker for Local Control in Patients With High-Risk T1 Bladder Cancer Treated With Transurethral Resection and Radiochemotherapy

(2009) Christian Weiss et al.   INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS

Predictive Value of Combined Immunohistochemical Markers in Patients With pT1 Urothelial Carcinoma at Radical Cystectomy

(2009) Shahrokh F. Shariat et al.   JOURNAL OF UROLOGY

Differential expression of survivin and its splice variants, survivin-ΔEx3 and survivin-2B, in bladder cancer

(2009) Yaser Atlasi et al.   Cancer Detection and Prevention

Prognostic Value of Combined p53 and Survivin in pT1G3 Urothelial Carcinoma of the Bladder

(2008) Samia Gonzalez et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Targeting survivin in cancer therapy

(2008) Marzia Pennati et al.   EXPERT OPINION ON THERAPEUTIC TARGETS